ctrl K

Luye Pharma Group Ltd. (LYPHF)

PNK: LYPHF · Real-Time Price · USD

0.27

0.01 (5.80%)

At close: Apr 29, 2025, 9:30 AM

Luye Pharma Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	6.14B	5.98B	5.2B	5.54B	6.36B	5.17B	3.81B	2.92B
Cost of Revenue	1.94B	1.84B	1.8B	1.55B	1.48B	1.12B	851.48M	535.05M
Gross Profit	4.2B	4.14B	3.4B	3.99B	4.88B	4.05B	2.96B	2.38B
Operating Income	1.03B	1.21B	386.99M	1.42B	1.99B	1.52B	1.09B	1.2B
Interest Income	117.14M	88.67M	102M	110.41M	95.94M	62.69M	27.64M	47.73M
Pretax Income	700.1M	669.76M	-74.56M	942.17M	1.77B	1.47B	1.12B	974.72M
Net Income	532.61M	604.81M	-144.78M	706.59M	1.47B	1.3B	981.37M	891.54M
Selling & General & Admin	2.7B	2.4B	2.28B	2.19B	2.56B	2.13B	1.72B	1.39B
Research & Development	586.16M	857.34M	683.16M	789.87M	579.46M	491.16M	288.7M	193.66M
Other Expenses	-110.84M	-73.26M	155.15M	-199.89M	-121.04M	7.81M	3.88M	3.15M
Operating Expenses	3.18B	3.19B	3.11B	2.78B	3.02B	2.53B	1.87B	1.47B
Interest Expense	675.45M	471.75M	399.46M	424M	274.61M	170.57M	50.44M	30.36M
Selling & Marketing Expenses	2.06B	1.82B	1.7B	1.66B	2.03B	1.69B	1.29B	1.12B
Cost & Expenses	5.11B	5.03B	4.92B	4.32B	4.5B	3.66B	2.72B	2B
Income Tax Expense	161.02M	86.47M	70.23M	238.91M	279.83M	167.47M	135.76M	80.73M
Shares Outstanding (Basic)	3.73B	3.48B	3.45B	3.19B	3.2B	3.21B	3.26B	3.32B
Shares Outstanding (Diluted)	3.73B	3.48B	3.45B	3.19B	3.22B	3.22B	3.26B	3.32B
EPS (Basic)	0.14	0.17	-0.04	0.22	0.46	0.41	0.30	0.27
EPS (Diluted)	0.14	0.17	-0.04	0.22	0.46	0.40	0.30	0.27
EBITDA	2.08B	1.81B	906.88M	1.88B	2.39B	1.96B	1.35B	1.15B
EBIT	1.38B	1.14B	324.9M	1.37B	1.93B	1.64B	1.17B	1.01B
Depreciation & Amortization	701.85M	671.31M	581.98M	510.9M	442.03M	317.19M	249.79M	140.92M